» Articles » PMID: 23867029

Lifestyle Interventions in Patients with Coronary Heart Disease: a Systematic Review

Overview
Journal Am J Prev Med
Specialty Public Health
Date 2013 Jul 23
PMID 23867029
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Coronary heart disease (CHD) is responsible for about 15% of all deaths worldwide and is identified as a top priority for decision makers. Both primary and secondary prevention are considered key strategies in the prevention of CHD. The aim of this study was to assess the efficacy of nonpharmacologic interventions with multiple lifestyle components in patients with established CHD in comparison to usual care. For this reason, a systematic review and meta-analysis of RCTs were performed.

Evidence Acquisition: The Cochrane Library, MEDLINE, and EMBASE databases were examined until March 31, 2012 (without start date) in order to identify studies addressing patient-tailored multifactorial lifestyle interventions aimed at reducing more than one cardiovascular risk factor in patients with established CHD. Primary endpoints were fatal and nonfatal cardiovascular events. Secondary outcomes were overall mortality and cardiovascular disease-associated hospital readmissions.

Evidence Synthesis: The search strategy yielded 14 unique RCTs, which were considered in the qualitative analysis. Nine of them contributed to the meta-analysis. A random effects model was used to pool the data. The meta-analysis showed a significant risk reduction of 18% (relative risk 0.82, 95% CI=0.69, 0.98) of fatal cardiovascular events in patients undergoing multifactorial lifestyle interventions. Further, a nonsignificant reduction of nonfatal events, overall mortality and hospital readmissions was found.

Conclusions: Multifactorial lifestyle interventions aimed at improving modifiable risk factors in patients with established CHD reduce the risk for fatal cardiovascular events. Therefore, they may have added value in secondary prevention of CHD.

Citing Articles

The Impact of Lifestyle Intervention Programs on Long-Term Cardiac Event-Free Survival in Patients With Established Coronary Artery Disease.

Kanemitsu K, Hassan B, Mdivnishvili M, Abbas N Cureus. 2025; 16(12):e76585.

PMID: 39881913 PMC: 11774816. DOI: 10.7759/cureus.76585.


A Medication Management App (Smart-Meds) for Patients After an Acute Coronary Syndrome: Pilot Pre-Post Mixed Methods Study.

Ehrler F, Gschwind L, Hagberg H, Meyer P, Blondon K JMIR Cardio. 2025; 9:e50693.

PMID: 39864094 PMC: 11781755. DOI: 10.2196/50693.


Beyond secondary prevention drugs: Added benefit in survival and events of a healthy lifestyle in patients after an acute coronary syndrome.

Rodriguez E, Kallmeyer A, Tarin N, Cristobal C, Huelmos A, Lazaro A Am J Prev Cardiol. 2025; 21():100923.

PMID: 39834624 PMC: 11745796. DOI: 10.1016/j.ajpc.2024.100923.


Cardiovascular Health Score and Atherosclerotic Cardiovascular Disease in the Million Veteran Program.

Nguyen X, Li Y, Gong Y, Houghton S, Ho Y, Pyatt M JAMA Netw Open. 2024; 7(12):e2447902.

PMID: 39641929 PMC: 11624584. DOI: 10.1001/jamanetworkopen.2024.47902.


The effect of multidomain lifestyle intervention on health care service use and costs - secondary analyses from the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): a randomised controlled trial.

Saaskilahti M, Kulmala J, Nurhonen M, Lehtisalo J, Peltonen M, Mangialasche F Age Ageing. 2024; 53(11).

PMID: 39577838 PMC: 11584201. DOI: 10.1093/ageing/afae249.